Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma

PURPOSE: This phase I clinical trial was conducted to determine the safety, efficacy, and molecular effects of sorafenib with temsirolimus in patients with advanced melanoma. PATIENTS AND METHODS: Patients with stage IV or unresectable or recurrent stage III melanoma and ECOG performance status of 0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Davies, Michael A., Fox, Patricia S., Papadopoulos, Nicholas E., Bedikian, Agop Y., Hwu, Wen-Jen, Lazar, Alexander J. F., Prieto, Victor G., Culotta, Kirk S., Madden, Timothy L., Xu, Quanyun, Huang, Sha, Deng, Wanleng, Ng, Chaan, Gupta, Sanjay, Liu, Wenbin, Dancey, Janet E., Wright, John J., Bassett, Roland L., Hwu, Patrick, Kim, Kevin B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906678/
https://ncbi.nlm.nih.gov/pubmed/22223528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2436
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge